A gender-independent proarrhythmic action of 17β-estradiol in anaesthetized rabbits

European Journal of Pharmacology

Volumn 575, Issue 1-3, 2007, Pages 113-121

  Philp, Karen L ^a   Hart, George ^a   Coker, Susan J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Arrhythmia; Estradiol; Estrogen; Gender; Long QT syndrome; Proarrhythmia; Repolarization; Sex hormone; Torsade de pointes

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CLOFILIUM; ESTRADIOL; PENTOBARBITAL;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; ELECTROCARDIOGRAM; ESTROGEN ACTIVITY; FEMALE; GENDER; HEART MUSCLE POTENTIAL; HEART PROARRHYTHMIA; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RABBIT; TORSADE DES POINTES;

ACTION POTENTIALS; ANESTHETICS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ESTRADIOL; FEMALE; HEART RATE; MALE; MYOCARDIAL ISCHEMIA; RABBITS; SEX CHARACTERISTICS; TIME FACTORS; TORSADES DE POINTES;

EID: 35348921843     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.035     Document Type: Article

References (43)

1. Abi-Gerges N., Philp K., Pollard C., Wakefield I., Hammond T.G., and Valentin J.P. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam. Clin. Pharmacol. 18 (2004) 139-151
2. Abi-Gerges N., Small B.G., Lawrence C.L., Hammond T.G., Valentin J.-P., and Pollard C.E. Evidence for gender differences in electrophysiological properties of canine Purkinje fibres. Br. J. Pharmacol. 142 (2004) 1255-1264
3. Batey A.J., and Coker S.J. Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes. Br. J. Pharmacol. 135 (2002) 1003-1012
4. Bednar M.M., Harrigan E.P., and Ruskin J.N. Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc. Am. J. Cardiol. 89 (2002) 1316-1319
5. Belardinelli L., Antzelevitch C., and Vos M.A. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol. Sci. 24 (2003) 619-625
6. Benton R.E., Sale M., Flockhart D.A., and Woosley R.L. Greater quinidine-induced QTc interval prolongation in women. Clin. Pharmacol. Ther. 67 (2000) 413-418
7. Berger F., Borchard U., Hafner D., Putz I., and Weis T.M. Effects of 17beta-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 788-796
8. Carlsson L., Almgren O., and Duker G. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions. J. Cardiovasc. Pharmacol. 16 (1990) 276-285
9. Carlsson L., Abrahamsson C., Drews L., and Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation 85 (1992) 1491-1500
10. ++ overload. J. Pharmacol. Exp. Ther. 279 (1996) 231-239
11. Chen Y.J., Lee S.H., Hsieh M.H., Hsiao C.J., Yu W.C., Chiou C.W., and Chen S.A. Effects of 17 beta-estradiol on tachycardia-induced changes of atrial refractoriness and cisapride-induced ventricular arrhythmia. J. Cardiovasc. Electrophysiol. 10 (1999) 587-598
12. Drici M.D., Burklow T.R., Haridasse V., Glazer R.I., and Woosley R.L. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94 (1996) 1471-1474
13. Ebert S.N., Liu X.K., and Woosley R.L. Female gender as a risk factor for drug-induced cardiac arrhythmias: Evaluation of clinical and experimental evidence. J. Women's Health 7 (1998) 547-557
14. Farkas A., and Coker S.J. Limited induction of torsade de pointes by terikalant and erythromycin in an in vivo model. Eur. J. Pharmacol. 449 (2002) 143-153
15. + channels. Eur. J. Pharmacol. 472 (2003) 189-196
16. Farkas A., Batey A.J., and Coker S.J. How to measure electrocardiographic QT interval in the anaesthetized rabbit. J. Pharmacol. Toxicol. Methods 50 (2004) 175-185
17. Hara M., Danilo Jr. P., and Rosen M.R. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J. Pharmacol. Exp. Ther. 285 (1998) 1068-1072
18. Haverkamp W., Breithardt G., Camm A.J., Janse M.J., Rosen M.R., Antzelevitch C., Escande D., Franz M., Malik M., Moss A., and Shah R. The potential for QT prolongation and pro-arrhythmia by non- anti-arrhythmic drugs: clinical and regulatory implications report on a policy conference of the European society of cardiology. Cardiovasc. Res. 47 (2000) 219-233
19. James A.F., Choisy S.C.M., and Hancox J.C. Recent advances in understanding sex differences in cardiac repolarization. Prog. Biophys. Mol. Biol. 94 (2007) 265-319
20. Johansson M., and Carlsson L. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome. J. Cardiovasc. Pharmacol. Ther. 6 (2001) 247-254
21. 2+ loading. J. Am. Coll. Cardiol. 36 (2000) 948-952
22. + channels in canine hearts. J. Mol. Cell. Cardiol. 32 (2000) 1147-1158
23. Lehmann M.H., Hardy S., Archibald D., and MacNeil D.J. JTc prolongation with d,l-sotalol in women versus men. Am. J. Cardiol. 83 (1999) 354-359
24. Liu X.K., Katchman A., Drici M.D., Ebert S.N., Ducic I., Morad M., and Woosley R.L. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J. Pharmacol. Exp. Ther. 285 (1998) 672-679
25. Liu X.K., Wang W., Ebert S.N., Franz M.R., Katchman A., and Woosley R.L. Female gender is a risk factor for torsades de pointes in an in vitro animal model. J. Cardiovasc. Pharmacol. 34 (1999) 287-294
26. Lu H.R., Marien R., Saels A., and De Clerck F. Are there sex-specific differences in ventricular repolarization or in drug-induced early after depolarizations in isolated rabbit purkinje fibers?. J. Cardiovasc. Pharmacol. 36 (2000) 132-139
27. Lu H.R., Remeysen P., Somers K., Saels A., and de Clerck F. Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model. J. Cardiovasc. Electrophysiol. 12 (2001) 538-545
28. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., and Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270 (1993) 2590-2597
29. Merri M., Benhorin J., Alberti M., Locati E., and Moss A. Electrocardiographic quantitation of ventricular repolarization. Circulation 80 (1989) 1301-1308
30. Michael G., Kane K.A., and Coker S.J. Repolarisation reserve and the development of torsade de pointes in models of long QT syndromes 1 and 2. J. Mol. Cell. Cardiol. 40 (2006) 985
31. Moller C., and Netzer R. Effects of estradiol on cardiac ion channel currents. Eur. J. Pharmacol. 532 (2006) 44-49
32. Moss A.J. Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. Am. J. Cardiol. 72 (1993) B23-B25
33. Pham T.V., and Rosen M.R. Sex, hormones, and repolarization. Cardiovasc. Res. 53 (2002) 740-751
34. K-blocking drugs. Circulation 103 (2001) 2207-2212
35. 2+ channel blockade. Br. J. Pharmacol. 149 (2006) 233-242
36. ATP channels in heart-derived H9c2 cells. J. Am. Coll. Cardiol. 40 (2002) 367-374
37. Tanabe S., Hata T., and Hiraoka M. Effects of estrogen on action potential and membrane currents in guinea pig ventricular myocytes. Am. J. Physiol. 277 (1999) H826-H833
38. ATP channels activated by 17β -estradiol on reperfusion arrhythmias and infarct sizes in canine hearts. J. Pharmacol. Exp. Ther. 301 (2002) 234-240
39. Valverde E.R., Biagetti M.O., Bertran G.R., Arini P.D., Bidoggia H., and Quinteiro R.A. Developmental changes of cardiac repolarization in rabbits: implications for the role of sex hormones. Cardiovasc. Res. 57 (2003) 625-631
40. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W.G., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Riemersma R.A., Riva E., Russell D.C., Sheridan D.J., Winslow E., and Woodward B. The Lambeth Conventions - guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
41. Welty F.K. Women and cardiovascular risk. Am. J. Cardiol. 88 (2001) 48-52
42. Wenger N.K. Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc. Res. 53 (2002) 558-567
43. Witchel H.J., and Hancox J.C. Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current. Clin. Exp. Pharmacol. Physiol. 27 (2000) 753-766